
The objective of this study is to evaluate the zzso zzso and long-term outcome of zzso IV zzso therapy with repeated frequent intervals in combination with oral and IV zzso in patients with zzso zzso In this study, 113 patients diagnosed as having zzso and zzso were assessed in between 1993 and 2002, with a median follow-up of zzso zzso The patients were treated with 500 zzso IV zzso and 1 g IV zzso together with 60 zzso oral zzso in a given zzso The clinical and laboratory data were zzso There were significant improvements in the clinical and the laboratory zzso Six patients died shortly after being hospitalized due to the disease activity zzso Eight patients were excluded from the study because of low zzso The zzso functions of the patients remained stable throughout the zzso only zzso patients needed one or two additional zzso Temporary zzso developed in zzso patients and diminished with the suspension or zzso of the IV zzso zzso zzso side effects, which needed extra medication, developed in 20 zzso zzso was observed in zzso zzso zzso abnormalities were seen in zzso zzso No serious infections due to zzso were observed with the given zzso zzso was observed in 13 patients zzso of zzso zzso maximum of zzso zzso and controlled with zzso zzso zzso zzso central obesity was observed in 15 of the zzso zzso was observed in one patient who died during the follow-up zzso zzso starting with the weekly zzso IV zzso to induce zzso together with IV and oral steroids, followed by prolonged intervals with the same doses for 2 years, appears to be useful in preserving zzso function without major side effects in patients with lupus zzso in comparison to other zzso 

